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Abstract The cardiac muscle isoform of the ryanodine receptor/Ca2’ release channel (RYR) has been proposed to be an important arget of cyclic 
ADP-ribose (cADPR) action in mammalian cells. However, we now demonstrate that neither cADPR (O.l-5pM), nor the related metabolitesp-NAD’ 
(0.1-30 mM) and ADP-ribose (0.1-5 PM), affected cardiac RYR activity as determined by [‘Hlryanodine binding to cardiac sarcoplasmic reticulum 
(SR) vesicles. Similarly, cADPR (1 PM) failed to activate single cardiac RYR channels in planar lipid bilayers. Skeletal muscle SR [‘Hlryanodine 
binding was also unaffected by cADPR (up to 30pM). These results argue against a direct role for the well-characterized RYRs of cardiac or skeletal 
muscle in mediating cADPR-activated Ca” release. 
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1. Introduction 
Cyclic ADP-ribose (cADPR) is an endogenous metabolite of 
NAD’ which releases Ca” from intracellular stores in sea ur- 
chin eggs and certain mammalian cell types [l-3]. Because 
cADPR-activated Ca” release in sea urchin eggs is sensitive to 
ryanodine, caffeine, and Ruthenium red, but insensitive to inos- 
itol 1,4,5 trisphosphate and heparin, it is considered that 
cADPR may operate through a member of the ryanodine re- 
ceptor (RYR) family of Ca” release channels. Indeed, RYR 
Ca2’ release channels have now been described in a variety of 
vertebrate and invertebrate cell types [4]. However, to date the 
best characterized RYR isoforms are those expressed in mam- 
malian cardiac and skeletal muscle, where they constitute the 
pathway for the rapid release of Ca*’ from the sarcoplasmic 
reticulum (SR) which triggers muscle contraction. 
Recently, the possibility that cardiac and skeletal muscle 
RYR isoforms may be targets of cADPR action has been inves- 
tigated. In particular, a report by Mtszaros et al. concluded 
that the cardiac RYR isoform (which is also expressed in the 
brain) may be an important pathway for cADPR-activated 
Ca2’ release [5]. At concentrations of l-2 PM, cADPR stimu- 
lated 45Ca2+ efIlux from both cardiac SR and brain microsomes, 
stimulated [3H]ryanodine binding to cardiac SR, and increased 
the open probability of single cardiac RYR channels in planar 
lipid bilayers. As RYR channel activation was observed only 
at submicromolar Ca2’ concentrations, the authors proposed 
that cADPR-activated Ca2’ release may represent an altema- 
tive mechanism to Ca2’-induced Ca2+ release for activation of 
the cardiac RYR channel [5]. 
The effect of cADPR on skeletal muscle RYR activity has 
been investigated by two laboratories. Meszaros et al. reported 
that cADPR had no effect on skeletal muscle SR Ca” et&x, 
yet showed a -70% inhibition of [‘Hlryanodine binding to skel- 
etal muscle SR in the presence of 2pM cADPR [5]. From these 
data the authors concluded that cADPR produced a conforma- 
tion change in the skeletal muscle RYR that inhibits ryanodine 
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binding without affecting SR Ca2’ release. In contrast, Morris- 
sette et al. reported that Ca2’ efflux from skeletal muscle SR 
vesicles was activated by 1-17 ,uM cADPR [6]. However, these 
authors also demonstrated that cADPR-activated Ca2’ efllux 
from skeletal muscle SR vesicles was insensitive to RYR chan- 
nel inhibitors, and that cADPR had no effect on single skeletal 
muscle RYR channels in planar bilayers. They concluded that 
skeletal muscle SR does exhibit a cADPR-activated Ca2’. re- 
lease pathway, but that this pathway operates through non- 
RYR channels [6]. 
To further investigate the potential role of RYRs in cADPR- 
activated Ca2’ release, we have examined the effect of cADPR 
on cardiac RYR [‘Hlryanodine binding and single channel ac- 
tivity in planar lipid bilayers. The effect of cADPR on skeletal 
muscle RYR [3H]ryanodine binding was also examined. Our 
results fail to confirm the findings of Meszaros et al. and rather 
suggest hat proposed effects of cADPR on intracellular Ca2’ 
release are not likely to be mediated via direct effects on cardiac 
or skeletal muscle RYR function. 
2. Materials and methods 
Cardiac muscle SR vesicles were prepared from porcine ventricular 
tissue as described [fl, except as noted. Briefly, following homogeniza- 
tion in 10 mM NaHCO,, membranes were pelleted and extracted in 
0.6 M KC], 20 mM Tris, (pH 6.8), resuspended in 10% sucrose, and 
stored frozen at -70°C. Porcine cardiac muscle SR vesicles were also 
prepared by the procedure [lo] used by Mtszaros et al. [5] to address 
possible differences between this preparation and our own. Skeletal 
muscle SR vesicles were prepared from porcine longissimus dorsi [8]. 
Briefly, membranes obtained by differential ultracentrifugation of a 
muscle homogenate were extracted with 0.6 M KCI and fractionated 
on discontinuous ucrose gradients. Membranes edimenting between 
3640% sucrose were collected and stored frozen at -70°C. All isola- 
tion buffers contained 1 @ml aprotinin, 1 @ml leupeptin, and 0.1 mM 
phenylmethylsulfonyl fluoride (PMSF) to minimize proteolysis. 
[‘H]Ryanodine binding was determined in media containing 0.2 mg 
SR protein/ml, 0.1 M KCI, 10 mM PIPES (adjusted to pH 7.0 with 
Tris), 2 mM CaCl,, 0.5 mM PMSF, 100 nM [‘Hlryanodine. EGTA and 
nitrilotriacetic acid were varied from 2.90-9.09 mM to achieve the 
desired range of ionized Ca” concentrations. Following 90 min incuba- 
tions at 37°C membranes were filtered onto Whatman GFlB filters and 
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washed with 8 ml ice-cold 0.1 M KCl, 10 mM PIPES buffer (pH 7.0). 
For determinations of nonspecific binding, incubations were performed 
in the presence of 20 FM nonradioactive ryanodine. 
The single channel activity of cardiac RYR channels in planar lipid 
bilayers was examined essentially as described [ll]. Bilayers were 
formed by painting a lipid mixture comprised of synthetic palmitoyl- 
oleyl-phosphatidylethanolamine, palmitoyl-oleyl-phosphatidylserine, 
and palmitoyl-oleyl-phosphatidylcholine dissolved in n-decane (50 mgj 
ml) in a 5 : 3 : 2 ratio by weight, across a 250 pm aperture in a Delrin 
cup. The recording solution was symmetric 400 mM cesium methylsul- 
fonate, 20 mM HEPES, pH 7.2. Analogue data from a custom-designed 
headstage and amplifier was filtered at 1,500 Hz through an &pole 
Bessel filter and digitized at 15,200 Hz for storage on a computer. 
Cardiac SR vesicles were added to the cis (cytoplasmic) chamber and 
incorporated into the bilayer using a pulsing protocol (-50 mV to +50 
mV) in the presence of a gradient of 400 mM/200 mM cesium methane- 
sulfonate, 20 mM HEPES, pH 7.2, 7 PM ionized Ca”. The gradient 
was dissipated after vesicle fusion by the addition concentrated cesium 
methanesulfonate o the trans chamber. RYR channels were identified 
by their characteristic Cs’ conductance of approximately 560 pS and 
by their inactivation in the presence of nanomolar Ca”. Whenever 
possible, channels were also identified by a characteristic response to 
ryanodine, caffeine, or ATP added at the conclusion of an experiment. 
Single channel data was collected using a pulsing protocol in which the 
potential was held at +70 mV for 990 ms, then pulsed to -70 mV for 
60 ms (CLAMPEX software, Axon Instruments). When two channels 
were present in the bilayer simultaneously (as indicated by current 
amplitudes two times the expected current amplitude) single channel 
percent open time (P,) was calculated as: 
P ~ioe/ + (P%“d x 2) I 2 
2 
cADPR was prepared and purified in the laboratory of Dr. H.C. Lee, 
University of Minnesota, following an established protocol (e.g. [2,5]). 
Briefly, cADPR was synthesized from NAD’ using ADP-ribosyl 
cyclase from Aplysiu ovotestis, and purified on an AG MP-1 column 
(Bio-Rad) using a gradient of trifluoroacetic acid. Concentrations of 
cADPR stock solutions were determined by absorbance at 254 nm 
using an extinction coefficient of 14,300. 
3. Results and discussion 
Ryanodine interacts with the open state of the RYR channel 
and thus its binding directly reflects RYR channel activity [9]. 
Accordingly, [3H]ryanodine binding to cardiac SR was acti- 
vated by 10 mM caffeine or by micromolar Ca2’, and was 
inhibited by 10 PM Ruthenium red; in contrast 1 ,uM cADPR 
had no effect on either the Ca2’ dependence or the magnitude 
of [3H]ryanodine binding to cardiac SR (Fig. 1A). Increasing 
cADPR concentrations up to 5 ,uM similarly had no significant 
effect on cardiac SR [3H]ryanodine binding at either 100 nM 
or 10 PM Ca” (Fig. 1B). The lack of an effect of cADPR on 
[3H]ryanodine binding cannot be explained by the hydrolysis of 
cADPR, because in control experiments, cADPR concentra- 
Table 1 
Absence of cADPR effect on cardiac RYR single channel P, 
p, (%I 
pCa 5 pCa 7 pCa 8 
Control 23.0 f 3.6 (9) 9.1 f 1.6 (4) 0.2 f 0.07 (5) 
1 PM cADPR _ 8.0 + 4.1 (4) 0.1 f 0.03 (5) 
Single channel percent open times were calculated from 215400 s of 
total recording time for each condition. Data represent means f. S.E. 
of the number of experiments indicated in parenthesis. P, values were 
not significantly different in the absence and presence of cADPR 
(p = 0.3 at pCa 8, student’s r-test). 
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Fig. 1. Absence of cADPR effect on [SH]ryanodine binding to cardiac 
muscle SR. (A) Ca” dependence of [‘Hlryanodine binding to cardiac 
SR in the absence (0) or presence of 10 mM caffeine (+), 10 PM 
Ruthenium red (T) or 1 PM cADPR (m). (B) Concentration dependence 
of cADPR and related metabolites on cardiac SR [‘Hlryanodine bind- 
ing at pCa 5 and pCa 7. (C) [‘H]Ryanodine binding to cardiac SR 
determined essentially as described [5,9] in the presence of 10 nM 
ryanodine, 300 mM KCl, 20 mM PIPES, pH 7.0, in the absence (0) and 
presence (m) of 5 PM cADPR; 16 h incubations at 20°C. (D) Effect of 
cADPR on [‘Hlryanodine binding to cardiac SR prepared as described 
[5,9]. Data in panels (A) and (B) are means of at least four determina- 
tions performed in the presence of 100 nM ryanodine, 100 mM KCl, 
10 mM PIPES buffer, pH 7.0 as described in section 2. Data in panels 
(C) and (D) are means of duplicate determinations. 
tions were unchanged following incubation with cardiac SR 
under our assay conditions (as determined by HPLC analysis, 
data not shown). Furthermore, neither the metabolic precursor 
of cADPR (NAD’) nor the product of its hydrolysis (ADPR) 
affected [3H]ryanodine binding to cardiac SR (Fig. 1B). 
The conditions of our [‘Hlryanodine binding assay differed 
somewhat from the assay conditions used by MCszPros et al. 
[5]. We therefore investigated the possibility that these differ- 
ences may have contributed to our inability to demonstrate an 
activation of [3H]ryanodine binding by cADPR. However, 
under conditions very similar to those used by MCszaros et al., 
cADPR (5 PM) again had no effect on cardiac SR [3H]ryan- 
odine binding (Fig. 1C). We also examined [3H]ryanodine bind- 
ing to cardiac SR prepared by the procedure [lo] used by 
MCszaros et al. [S]. However, 1 ,uM cADPR again had no effect 
on [3H]ryanodine binding to this preparation (Fig. 1D). Thus, 
our results fail to confirm the stimulation of [3H]ryanodine 
binding to cardiac SR (-450% stimulation in the presence of 
2 PM cADPR, 100 nM Ca”) reported by MCszaros et al. [S]. 
The failure of cADPR to activate the cardiac RYR was 
confirmed by examining the single-channel open probability 
(P,) of cardiac RYR incorporated into planar lipid bilayers. 
The representative experiment shown indicates two channels in 
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Fig. 2. Absence of cADPR effect on porcine cardiac RYR channels 
incorporated into lipid bilayers. Representive 858 ms traces are shown 
under control conditions (A, pCa 5; PO = 22%) and following subse- 
quent additions of 150 ,uM EGTA (B, pCa 8; PO = 0.2%), 1 ,uM cADPR 
(C, P, = 0.1%) and 1.5 mM caffeine and 10 mM ATP (D, PO = 0.8%). 
Arrows at the upper right indicate current amplitudes for 0, 1, and 2 
open channels. Records are from an experiment performed in the pres- 
ence of symmetric 400 mM cesium methylsulfonate, 20 mM HEPES, 
pH 7.2, at a potential of +70 mV. 
the bilayer, each with a unitary current amplitudes of 42 pA 
(Fig. 2). In the presence of 10 ,uM Ca”, channels were fre- 
quently in the open state as indicated by upward deflections 
(Fig. 2A; PO = 22%). Addition of 150,~M EGTA to the cis and 
tram chambers decreased the free Ca2’ concentration to ap- 
proximately 10 nM (as determined by a Ca” electrode) and 
decreased the single channel open probability to near zero (Fig. 
2B; P, = 0.2%). Symmetric addition of 1 PM cADPR failed to 
stimulate RYR channel activity (Fig. 2C; P, = 0.1%). However, 
the subsequent addition of 1.5 mM caffeine and 10 mM ATP 
increased the single channel P, and demonstrated the continued 
presence of two channels in the bilayer (Fig. 2D; P, = 0.8%). 
A summary of similar experiments (Table 1) demonstrates no 
significant effect of cADPR on cardiac RYR single channel P, 
in the presence of either 10 nM or 100 nM Ca2’. These results 
contrast with the data of Meszaros et al. [5] who reported a 
390% increase in open probability in the presence of 1 PM 
cADPR and 10 nM Ca2+. 
The effect of cADPR on [3H]ryanodine binding to skeletal 
muscle SR was also examined. Skeletal muscle SR [3H]ryan- 
odine binding was maximally activated by l-10 ,uM Ca2’ and 
inhibited by millimolar Ca2’; cADPR (l-30 PM) had no signif- 
icant effect on skeletal muscle SR [‘Hlryanodine binding at any 
Ca” concentration examined (Fig. 3). These results thus fail to 
confirm the inhibition by cADPR of skeletal muscle SR [3H]ry- 
anodine binding (-70% inhibition at 100 PM Ca2’ and -46% 
inhibition at 10 PM Ca*‘, in the presence of 2 ,uM cADPR) 
reported by Meszaros et al. [5]. Our results, however, are con- 
sistent with those of Morrissette et al. [6] showing no effect of 
1-17 ,LLM cADPR on skeletal muscle RYR single channel 
activity. 
Ryanodine receptors have been shown to be regulated by a 
variety of physiological igands. For example, adenine nucleo- 
tides, Mg *+ H’ inorganic phosphate, sphingosine, acyl carniti- , 
nes, and calmodulin, as well as Ca*‘, regulate the opening 
and/or closing of RYR channels in vitro [4,12,13,17]. RYR 
activity is similarly modulated by a variety of non-physiological 
ligands including ryanodine, caffeine, Ruthenium red, pro- 
caine, halothane, perchlorate, and certain peptide toxins 
[4,14,15,17]. The effects of these various ligands on RYR activ- 
ity can be demonstrated by corresponding changes in 45Ca2+ 
efflux, [3H]ryanodine binding, and single RYR channel activity 
in planar lipid bilayers. Thus, it is difficult to reconcile our 
results showing no effect of cADPR on either [3H]ryanodine 
binding or RYR channel activity in bilayers with the proposed 
activation of cardiac muscle RYRs by this metabolite [5]. 
In sea urchin eggs, cADPR-binding proteins with apparent 
molecular masses of 100 kDa and 140 kDa have been identified 
by photoaffinity labelling with 8azido-cADPR [16]. As these 
proteins are considerably smaller than the -565 kDa subunits 
which form cardiac and skeletal muscle RYRs, it is possible 
that they constitute a novel intracellular Ca2’ release pathway. 
Alternatively, it has been suggested [16] that the proteins iden- 
tified by photoaffinity labelling may represent accessory pro- 
teins that interact with high molecular weight RYR channels 
after binding cADPR. Similarly, activation of cardiac RYRs by 
cADPR might be postulated to depend on interactions with as 
yet unidentified accessory proteins. In this view, our inability 
to demonstrate activation of cardiac RYRs by cADPR might 
be attributed to differences in our preparations or methods that 
somehow prevented the interaction of accessory proteins with 
RYRs. However, this explanation seems unlikely in that we 
were unable to demonstrate activation of cardiac RYRs by 
cADPR using SR preparations [7,10] and methods of monitor- 
ing RYR activity similar to those used by Meszaros et al. [5]. 
In conclusion, we have been unable to reproduce the effects 
of cADPR on [3H]ryanodine binding to cardiac and skeletal 
muscle SR reported by Meszaros et al. [5]. In addition, we have 
failed to confirm the reported stimulation by cADPR of cardiac 
RYR single-channel activity in lipid bilayers [5]. Meszaros et 
al. also reported a significant effect of cADPR on 45Ca2’ e&ix 
from cardiac muscle SR and brain microsomes. However, these 
data by themselves do not prove that cADPR-activated Ca2’ 
eftlux is mediated by cardiac RYR channels, or even demon- 
strate that this effect of cADPR can be blocked by known RYR 
inhibitors [5]. Therefore, based on the [3H]ryanodine binding 
and single-channel activity determinations reported here, we 
conclude that cADPR has no direct effects on the functional 
activity of either cardiac or skeletal muscle RYR isoforms. This 
suggests that cADPR-activated Ca2’ release in muscle and 
other cell types may operate through pathways which are dis- 
tinct from these well-characterized RYR channels. 
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Fig. 3. Absence of cADPR effect on [‘Hlryanodine binding to skeletal 
muscle SR. (A) Ca” dependence of [‘Hlryanodine binding to skeletal 
muscle SR in the absence (0) or presence of 1 PM cADPR (m). (B) Effect 
of l-30 pM cADPR on skeletal muscle SR [3H]ryanodine binding at 
pCa 3, pCa 5 and pCa 7. Data represent means from two experiments 
(A) or triplicate determinations from a single experiment (B), per- 
formed as described in section 2. 
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